SILVIA COELLO: Open Payments
NPI 1265967889 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 63 payments from 12 companies in 2025. Trend: 2023 $202 · 2024 $894 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $236 |
| ABBVIE INC. | 12 | $205 |
| Ardelyx, Inc. | 9 | $191 |
| Aimmune Therapeutics, Inc. | 6 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $144 |
| QOL Medical, LLC | 7 | $126 |
| Celltrion USA Inc. | 3 | $77 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Lilly USA, LLC | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: TREMFYA, IBSRELA, ZENPEP, Sucraid, LINZESS, ENTYVIO, VEGZELMA, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
